Reuters logo
BRIEF-Achillion says ACH-4471 granted orphan drug designation by FDA
November 6, 2017 / 11:27 AM / a month ago

BRIEF-Achillion says ACH-4471 granted orphan drug designation by FDA

Nov 6 (Reuters) - Achillion Pharmaceuticals Inc

* Achillion announces ACH-4471 granted orphan drug designation by the FDA and positive opinion for orphan drug designation in the european union for the treatment of paroxysmal nocturnal hemoglobinuria

* Achillion Pharma - ‍EMA committee for orphan medicinal products issued a positive opinion on ACH-4471 for orphan status in EU for treatment of PNH​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below